Literature DB >> 25104237

Diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health Survey cohorts.

Vanessa L Z Gordon-Dseagu1, Nicola Shelton2, Jennifer Mindell3.   

Abstract

BACKGROUND: Diabetes mellitus is associated with differing rates of all-cause and cause-specific mortality compared with the general population; although the strength of these associations requires further investigation. The effects of confounding factors, such as overweight and obesity and the presence of co-morbid cardiovascular disease (CVD), upon such associations also remain unclear. There is thus a need for studies which utilise data from nationally-representative samples to explore these associations further.
METHODS: A cohort study of 204,533 participants aged 16+ years (7,199 with diabetes) from the Health Survey for England (HSE) (1994-2008) and Scottish Health Survey (SHeS) (1995, 1998 and 2003) linked with UK mortality records. Odds ratios (ORs) of all-cause and cause-specific mortality and 95% confidence intervals were estimated using logistic and multinomial logistic regression.
RESULTS: There were 20,051 deaths (1,814 among those with diabetes). Adjusted (age, sex, and smoking status) ORs for all-cause mortality among those with diabetes was 1.68 (95%CI 1.57-1.79). Cause-specific mortality ORs were: cancer 1.26 (1.13-1.42), respiratory diseases 1.25 (1.08-1.46), CVD 1.96 (1.80-2.14) and 'other' causes 2.06 (1.84-2.30). These were not attenuated significantly after adjustment for generalised and/or central adiposity and other confounding factors. The odds of mortality differed between those with and without comorbid CVD at baseline; the ORs for the latter group were substantially increased.
CONCLUSIONS: In addition to the excess in CVD and all-cause mortality among those with diabetes, there is also increased mortality from cancer, respiratory diseases, and 'other' causes. This increase in mortality is independent of obesity and a range of other confounding factors. With falling CVD incidence and mortality, the raised risks of respiratory and cancer deaths in people with diabetes will become more important and require increased health care provision.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  All-cause; Cancer; Cardiovascular disease; Diabetes; Respiratory disease

Mesh:

Year:  2014        PMID: 25104237     DOI: 10.1016/j.jdiacomp.2014.06.016

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  14 in total

1.  Cohort Profile: The Maule Cohort (MAUCO).

Authors:  Catterina Ferreccio; Andrea Huidobro; Sandra Cortés; Claudia Bambs; Pablo Toro; Vanessa Van De Wyngard; Johanna Acevedo; Fabio Paredes; Pía Venegas; Hugo Verdejo; Ximena Oyarzún-González; Paz Cook; Pablo F Castro; Claudia Foerster; Claudio Vargas; Jill Koshiol; Juan Carlos Araya; Francisco Cruz; Alejandro H Corvalán; Andrew F Quest; Marcelo J Kogan; Sergio Lavandero
Journal:  Int J Epidemiol       Date:  2020-06-01       Impact factor: 7.196

2.  A Cohort Study of Adolescent and Midlife Diet and Pancreatic Cancer Risk in the NIH-AARP Diet and Health Study.

Authors:  Vanessa L Z Gordon-Dseagu; Frances E Thompson; Amy F Subar; Elizabeth H Ruder; Anne C M Thiébaut; Nancy Potischman; Rachael Stolzenberg-Solomon
Journal:  Am J Epidemiol       Date:  2017-08-01       Impact factor: 4.897

Review 3.  Determinants of mortality in patients with type 2 diabetes: a review.

Authors:  Jana Engelmann; Ulf Manuwald; Constanze Rubach; Joachim Kugler; Andreas L Birkenfeld; Markolf Hanefeld; Ulrike Rothe
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

4.  Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression.

Authors:  Marta Novak; Istvan Mucsi; Connie M Rhee; Elani Streja; Jun L Lu; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Csaba P Kovesdy
Journal:  Diabetes Care       Date:  2016-06-16       Impact factor: 19.112

5.  Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.

Authors:  Peter Bramlage; Anselm K Gitt; Steffen Schneider; Evelin Deeg; Diethelm Tschöpe
Journal:  BMC Cardiovasc Disord       Date:  2014-11-19       Impact factor: 2.298

6.  Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events.

Authors:  Toshiaki Ohkuma; Sanne A E Peters; Mark Woodward
Journal:  Diabetologia       Date:  2018-07-20       Impact factor: 10.122

7.  Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register.

Authors:  Andri O Steinarsson; Araz Rawshani; Soffia Gudbjörnsdottir; Stefan Franzén; Ann-Marie Svensson; Naveed Sattar
Journal:  Diabetologia       Date:  2018-01-09       Impact factor: 10.122

8.  Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants.

Authors:  Yafeng Wang; Adrienne O'Neil; Yurui Jiao; Lijun Wang; Jingxin Huang; Yutao Lan; Yikun Zhu; Chuanhua Yu
Journal:  BMC Med       Date:  2019-07-12       Impact factor: 8.775

9.  Association between Diabetes and Risk of Aortic Dissection: A Case-Control Study in a Chinese Population.

Authors:  Xingwei He; Xintian Liu; Wanjun Liu; Bei Wang; Yujian Liu; Zhuxi Li; Tao Wang; Rong Tan; Bo Gao; Hesong Zeng
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

10.  Diabetes and Mortality From Respiratory Diseases: The Japan Collaborative Cohort Study.

Authors:  Mengying Wang; Isao Muraki; Keyang Liu; Kokoro Shirai; Akiko Tamakoshi; Yonghua Hu; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2019-12-14       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.